Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting (Smartfitting)
Primary Purpose
Diabetic Foot, Orthopedic Disorder, Foot Ankle Injuries
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Sponsored by
About this trial
This is an interventional prevention trial for Diabetic Foot focused on measuring Prevention, Therapeutic footwear, New technologies
Eligibility Criteria
Inclusion Criteria:
- High risk patients according to the International Working Group Diabetic Foot Guidelines (IWGDF-risk 3).
- Healed diabetic foot ulcer at the moment of inclusion.
- Capability to walk autonomously without walking aids.
- Diabetic Peripheral neuropathy.
Exclusion Criteria:
- Major amputation in the contralateral limb (below or above the knee).
Sites / Locations
- Clínica Universitaria de Podología de la Universidad Complutense de Madrid
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Standard Therapeutic Footwear prescription group
Therapeutic Footwear prescription based on a 3D Foot scanner
Arm Description
1) Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences
2) Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Outcomes
Primary Outcome Measures
The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.
Validation of proper therapeutic footwear fitting was performed by a specialized podiatrist after acquisition of shoes in both groups. TF was recommended to change when following ill fitting reason were found: excessive length or tight, or compromise with toes
Secondary Outcome Measures
Number of participants with an ulcer occurrence event
Presence of a new o previous ulcer located in the foot in a patient with diabetes
Full Information
NCT ID
NCT05353114
First Posted
April 22, 2022
Last Updated
November 2, 2022
Sponsor
Universidad Complutense de Madrid
1. Study Identification
Unique Protocol Identification Number
NCT05353114
Brief Title
Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting
Acronym
Smartfitting
Official Title
Clinical Efficacy of a 3D Foot Scanner App for the Fitting of Therapeutic Footwear in Persons With Diabetes in Remission: A Randomized and Controlled Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
June 15, 2022 (Actual)
Primary Completion Date
June 30, 2022 (Actual)
Study Completion Date
July 15, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Complutense de Madrid
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients with diabetes at high risk of ulceration require a perfect fitting shoe to avoid high shear and pressure forces. Neuropathy skews sensory perceptions and can alter the proper selection of the therapeutic footwear.
The aims of study were to evaluate the ability of high-risk patients with diabetes in remission to select the proper therapeutic footwear and to validate a novel 3D foot scanner app for selecting the proper fitting therapeutic footwear.
Detailed Description
A Randomized Controlled Clinical Trial in 30 patients with a previous healed diabetic foot ulcer.
After parallel randomization (1:1) patients will be enrolled into two different groups:
Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences;
Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Validation of proper therapeutic footwear fitting will be performed by a specialized podiatrist after acquisition of shoes in both groups.
Therapeutic Footwear will be recommended to change when following ill fitting reason been found: excessive length or tight, or compromise with toes
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot, Orthopedic Disorder, Foot Ankle Injuries
Keywords
Prevention, Therapeutic footwear, New technologies
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Standard Therapeutic Footwear prescription group
Arm Type
No Intervention
Arm Description
1) Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences
Arm Title
Therapeutic Footwear prescription based on a 3D Foot scanner
Arm Type
Experimental
Arm Description
2) Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Intervention Type
Other
Intervention Name(s)
3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Intervention Description
The 3D foot scan becomes a movile app that recommends a specific size and model of therapeutic footwear according to the measurements
Primary Outcome Measure Information:
Title
The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.
Description
Validation of proper therapeutic footwear fitting was performed by a specialized podiatrist after acquisition of shoes in both groups. TF was recommended to change when following ill fitting reason were found: excessive length or tight, or compromise with toes
Time Frame
1 week
Secondary Outcome Measure Information:
Title
Number of participants with an ulcer occurrence event
Description
Presence of a new o previous ulcer located in the foot in a patient with diabetes
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
High risk patients according to the International Working Group Diabetic Foot Guidelines (IWGDF-risk 3).
Healed diabetic foot ulcer at the moment of inclusion.
Capability to walk autonomously without walking aids.
Diabetic Peripheral neuropathy.
Exclusion Criteria:
Major amputation in the contralateral limb (below or above the knee).
Facility Information:
Facility Name
Clínica Universitaria de Podología de la Universidad Complutense de Madrid
City
Madrid
ZIP/Postal Code
28040
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting
We'll reach out to this number within 24 hrs